NEW YORK (GenomeWeb) – Some developers of noninvasive prenatal tests in Europe are taking a different strategy than those in the US, choosing to focus on launching CE-marked in vitro diagnostic tests that clinical laboratories can purchase as a kit, as opposed to offering laboratory-developed tests as a service.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.